Cas no 21752-34-1 ((S)-4-oxo-4-(1-phenylethylamino)butanoic Acid)
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid Chemical and Physical Properties
Names and Identifiers
-
- Butanoic acid,4-oxo-4-[[(1S)-1-phenylethyl]amino]-
- (S)-(?)-N-(1-Phenylethyl)succinamic acid
- (S)-N-(1-Phenylethyl)Succinic Acid Monoamide
- 4-oxo-4-[[(1S)-1-phenylethyl]amino]butanoic acid
- (S)-(-)-N-(1-Phenylethyl)succinaMic acid
- (S)-()-N-(1-Phenylethyl)succinamidic acid
- (S)-()-N-(alpha-Methylbenzyl)succinamidic acid
- 4-oxo-4-{[(1S)-1-phenylethyl]amino}butanoic acid
- AS-81166
- (S)-()-N-(1-Phenylethyl)succinamic acid
- DTXSID001237828
- EN300-383832
- CS-0247974
- E84849
- (S)-4-Oxo-4-((1-phenylethyl)amino)butanoic acid
- 21752-34-1
- (S)-4-Oxo-4-((1-phenylethyl)amino)butyric acid
- (S)-4-Oxo-4-((1-phenylethyl)amino)butanoicacid
- SCHEMBL3076773
- 3-{[(1S)-1-phenylethyl]carbamoyl}propanoic acid
- (S)-(-)-N-(1-Phenylethyl)succinamic acid, 98%
- EINECS 244-569-5
- (S)-4-oxo-4-(1-phenylethylamino)butanoic acid
- J-014273
- NS00084333
- (S)-N-(1-Phenylethyl)succinamic acid
- WUEKFTPKHWMMIP-VIFPVBQESA-N
- (S)-4-oxo-4-(1-phenylethylamino)butanoic Acid
-
- MDL: MFCD00077433
- Inchi: 1S/C12H15NO3/c1-9(10-5-3-2-4-6-10)13-11(14)7-8-12(15)16/h2-6,9H,7-8H2,1H3,(H,13,14)(H,15,16)/t9-/m0/s1
- InChI Key: WUEKFTPKHWMMIP-VIFPVBQESA-N
- SMILES: O=C(CCC(=O)O)N[C@@H](C)C1C=CC=CC=1
Computed Properties
- Exact Mass: 221.10525
- Monoisotopic Mass: 221.105193
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 16
- Rotatable Bond Count: 6
- Complexity: 247
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 66.4
- XLogP3: 0.9
Experimental Properties
- Color/Form: solid
- Density: 1.167
- Melting Point: 100-104?°C (lit.)
- Boiling Point: 470°C at 760 mmHg
- Flash Point: 238°C
- Refractive Index: 1.54
- PSA: 66.4
- Optical Activity: [α]24/D ?111°, c =?2 in ethanol
- Solubility: Not determined
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 461431-5G |
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid |
21752-34-1 | 5g |
¥2107.25 | 2023-12-06 | ||
| TRC | O847183-100mg |
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid |
21752-34-1 | 100mg |
$ 50.00 | 2022-06-03 | ||
| TRC | O847183-500mg |
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid |
21752-34-1 | 500mg |
$ 115.00 | 2022-06-03 | ||
| TRC | O847183-1g |
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid |
21752-34-1 | 1g |
$ 160.00 | 2022-06-03 | ||
| Aaron | AR003D45-250mg |
(S)-()-N-(1-Phenylethyl)succinamic acid |
21752-34-1 | 97% | 250mg |
$145.00 | 2025-01-22 | |
| eNovation Chemicals LLC | Y1249385-100mg |
(S)-()-N-(1-Phenylethyl)succinamic acid |
21752-34-1 | 97% | 100mg |
$150 | 2025-02-20 | |
| eNovation Chemicals LLC | Y1249385-250mg |
(S)-()-N-(1-Phenylethyl)succinamic acid |
21752-34-1 | 97% | 250mg |
$190 | 2025-02-20 | |
| Key Organics Ltd | AS-81166-1g |
3-{[(1S)-1-phenylethyl]carbamoyl}propanoic acid |
21752-34-1 | >97% | 1g |
£213.00 | 2025-02-08 | |
| Key Organics Ltd | AS-81166-0.25g |
3-{[(1S)-1-phenylethyl]carbamoyl}propanoic acid |
21752-34-1 | >97% | 0.25g |
£98.00 | 2025-02-08 | |
| Key Organics Ltd | AS-81166-5g |
3-{[(1S)-1-phenylethyl]carbamoyl}propanoic acid |
21752-34-1 | >97% | 5g |
£539.00 | 2025-02-08 |
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid Suppliers
(S)-4-oxo-4-(1-phenylethylamino)butanoic Acid Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
Additional information on (S)-4-oxo-4-(1-phenylethylamino)butanoic Acid
(S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid: A Comprehensive Overview
(S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid, also known by its CAS number 21752-34-1, is a significant compound in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The molecule is characterized by its amino acid-like structure, with a phenyl group attached to an ethylamine moiety, making it a valuable substrate for various biochemical and pharmacological studies.
The structural integrity of (S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid lies in its chiral center, which imparts stereochemical specificity. This feature is crucial in biological systems, where the spatial arrangement of molecules often determines their activity and interactions. Recent studies have highlighted the importance of stereochemistry in drug design, emphasizing the role of chiral compounds like this one in achieving desired therapeutic effects with minimal side effects.
One of the most notable aspects of this compound is its potential as a precursor in peptide synthesis. The presence of an amino group and a carboxylic acid group makes it an ideal building block for constructing more complex peptide structures. Researchers have explored its use in synthesizing bioactive peptides, which are increasingly being used in the development of novel therapeutics for conditions such as cancer, neurodegenerative diseases, and infectious disorders.
In addition to its role in peptide synthesis, (S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid has been investigated for its pharmacokinetic properties. Studies have shown that the compound exhibits favorable absorption and distribution profiles, making it a promising candidate for drug delivery systems. Its ability to penetrate cellular membranes efficiently suggests potential applications in targeted drug delivery, where precise control over drug release is critical.
The latest research on this compound has also delved into its enzymatic activity. Scientists have discovered that it can act as a substrate for certain proteases, enzymes responsible for breaking down proteins. This finding opens up new avenues for studying enzyme mechanisms and developing inhibitors for therapeutic purposes. The compound's interaction with proteases has been particularly interesting, as it provides insights into how small molecules can modulate enzymatic activity.
Furthermore, the compound's stability under various conditions has been a focal point of recent investigations. Researchers have found that (S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid maintains its structural integrity even under harsh conditions, such as high temperatures or extreme pH levels. This stability is advantageous for industrial applications, where compounds are often subjected to rigorous processing during manufacturing.
In terms of synthetic routes, chemists have developed several efficient methods to synthesize this compound. These methods include both traditional organic synthesis techniques and modern catalytic approaches. The development of scalable synthesis pathways has been particularly important for meeting the growing demand for this compound in research and industrial settings.
The compound's versatility is further underscored by its application in analytical chemistry. It serves as a reference standard for chromatographic separations, aiding in the accurate identification and quantification of similar compounds. Its use in quality control processes ensures the reliability and consistency of analytical results across different laboratories.
Looking ahead, ongoing research aims to explore the therapeutic potential of (S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid in more depth. Collaborative efforts between academic institutions and pharmaceutical companies are focusing on optimizing its bioavailability and efficacy when administered as a drug candidate. These efforts are expected to yield significant breakthroughs in the near future.
In conclusion, (S)-4-Oxo-4-(1-phenylethylamino)butanoic Acid stands out as a multifaceted compound with wide-ranging applications in chemistry and pharmacology. Its unique structure, stereochemical properties, and versatile functionality make it an invaluable tool for researchers across various disciplines. As ongoing studies continue to uncover new insights into its properties and applications, this compound is poised to play an even greater role in advancing scientific knowledge and therapeutic innovation.
21752-34-1 ((S)-4-oxo-4-(1-phenylethylamino)butanoic Acid) Related Products
- 64984-60-7(3-(benzylcarbamoyl)propanoic acid)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)